Death-associated protein kinase 1 variation and Parkinson's disease

European Journal of Neurology

Volumn 18, Issue 8, 2011, Pages 1090-1093

  Dachsel, J C ^a   Wider, C ^a,b   Vilarino Guell C ^a   Aasly, J O ^c,d   Rajput, A ^e   Rajput, A H ^e   Lynch, T ^f   Craig, D ^g   Krygowska Wajs, A ^h   Jasinska Myga, B ^a,i   Opala, G ⁱ   Barcikowska, M ^j   Czyzewski, K ^k   Wu, R M ^l   Heckman, M G ^m   Uitti, R J ^m   Wszolek, Z K ^m   Farrer, M J ^a   Ross, O A ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e SASKATOON HEALTH REGION   (Canada)

^f MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^g QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^h JAGIELLONIAN UNIVERSITY   (Poland)

ⁱ MEDICAL UNIVERSITY OF SILESIA   (Poland)

^j MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^k CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^l NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^m MAYO CLINIC   (United States)

more..

Author keywords

DAPK1; Genetics; LRRK2; Parkinson's disease

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; DEATH ASSOCIATED PROTEIN KINASE 1; LEUCINE RICH REPEAT KINASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TAIWAN;

EID: 79960321717     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03255.x     Document Type: Article

References (16)

1. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet 2006; 7: 306-318.
2. Marin I, van Egmond WN, van Haastert PJ. The Roco protein family: a functional perspective. FASEB J 2008; 22: 3103-3110.
3. Deng J, Lewis PA, Greggio E, Sluch E, Beilina A, Cookson MR. Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase. Proc Natl Acad Sci U S A 2008; 105: 1499-1504.
4. Klein CL, Rovelli G, Springer W, Schall C, Gasser T, Kahle PJ. Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment. J Neurochem 2009; 111: 703-715.
5. Dachsel JC, Nishioka K, Vilarino-Guell C, et al. Heterodimerization of Lrrk1-Lrrk2: implications for LRRK2-associated Parkinson disease. Mech Ageing Dev 2010; 131: 210-214.
6. Yamamoto M, Hioki T, Ishii T, Nakajima-Iijima S, Uchino S. DAP kinase activity is critical for C(2)-ceramide-induced apoptosis in PC12 cells. Eur J Biochem 2002; 269: 139-147.
7. Pelled D, Raveh T, Riebeling C, et al. Death-associated protein (DAP) kinase plays a central role in ceramide-induced apoptosis in cultured hippocampal neurons. J Biol Chem 2002; 277: 1957-1961.
8. Schori H, Yoles E, Wheeler LA, Raveh T, Kimchi A, Schwartz M. Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity. Eur J Neurosci 2002; 16: 557-564.
9. Heinzen EL, Need AC, Hayden KM, et al. Genome-wide scan of copy number variation in late-onset Alzheimer's disease. J Alzheimers Dis 2010; 19: 69-77.
10. Li Y, Grupe A, Rowland C, et al. DAPK1 variants are associated with Alzheimer's disease and allele-specific expression. Hum Mol Genet 2006; 15: 2560-2568.
11. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999; 56: 33-39.
12. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002; 70: 425-434.
13. Taylor JP, Hulihan MM, Kachergus JM, et al. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's disease. Neurogenetics 2007; 8: 95-102.
14. Bialik S, Bresnick AR, Kimchi A. DAP-kinase-mediated morphological changes are localization dependent and involve myosin-II phosphorylation. Cell Death Differ 2004; 11: 631-644.
15. Ho CC, Rideout HJ, Ribe E, Troy CM, Dauer WT. The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration. J Neurosci 2009; 29: 1011-1016.
16. Wang L, Xie C, Greggio E, et al. The chaperone activity of heat shock protein 90 is critical for maintaining the stability of leucine-rich repeat kinase 2. J Neurosci 2008; 28: 3384-3391.